Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 515 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Frontage extends pain medication development services

The approval enables pharma firms that develop pain therapeutics to rely on Frontage for controlled-substance product development support services. Frontage has upgraded its units, security and personnel procedures

FDA approves Mylan’s ANDA for Acyclovir Ointment

Acyclovir Ointment is the generic equivalent to Zovirax Ointment from Valeant International. Mylan has begun immediate product shipment. Zovirax Ointment is indicated for the management of initial genital